Q&A

Guiding Customers Through Drug Development Challenges With Intelligent Collaboration

Decreasing Timelines In Infectious Diseases Drug Development

Taking on the role as General Manager of Pfizer CentreOne, JoyL Silva leads Pfizer’s embedded contract development and manufacturing organization (CDMO).  JoyL brings a wide range of commercial, strategy, and business leadership experience spanning her 20-year career at Pfizer. Following is a recent discussion with JoyL around what it’s like to lead an embedded CDMO within one of the largest pharmaceutical companies and where the Pfizer CentreOne business is headed.

You’ve held some exciting leadership roles in Pfizer and are now managing the company’s prominent CDMO business. What have you learned from the transition?

When transitioning to Pfizer CentreOne, I hit the road … a lot. I have spent time with our manufacturing sites, our scientists, quality, commercial / marketing teams and especially with our customers. This time spent has given me confidence in who we are, the intelligent collaborators we’ve become and why we are uniquely positioned in the market to offer a full range of products. That includes our APIs and intermediates business as well as strategic contract drug development and manufacturing service offerings to customers.

VIEW THE Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma